Primary Article

Eclampsia Treatment and Referral

Authors: BAHA M. SIBAI MD, JACK H. McCUBBIN MD, GARLAND D. ANDERSON MD, PRESTON V. DILTS JR. MD

Abstract

ABSTRACTAlthough the recognition and treatment of preeclampsia theoretically should eliminate eclampsia, it has not disappeared and remains a substantial threat to maternal and fetal well-being. The therapy of choice for treatment and prevention of convulsions is magnesium sulfate (MgS04–7H20 USP) and that for severe hypertension is intravenous hydralazine. Delivery of the fetus and placenta is recommended after die mother is stabilized from the effects of the convulsion(s). If the mother is to be transported before delivery, it is important that she receive an adequate dose of MgS04

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References